BMS Looks To Utilize Cash Reserves To Break Into Japan's Top Tier
This article was originally published in PharmAsia News
Executive Summary
TOKYO - Bristol-Myers Squibb Co. expects to stop a five-year skid in Japan sales by the end of FY2011, and CEO Lamberto Andreotti said the company will utilize its large cash reserves for new business development opportunities in an effort to become a top 20 company in Japan